Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Long-acting nanomedicine for brain diseases | Synapse
March 3, 2026
Long-acting nanomedicine for brain diseases
JL
Jun Liao
Peking University
QH
Qi Huang
University of Shanghai for Science and Technology
RL
Ruiyu Li
Peking University
See all
Key Points
Effective drug delivery systems using biodegradable polymers are critical for targeting brain diseases.
Incorporating liposomes enhances the stability and efficacy of nanomedicine treatments.
This method may improve therapeutic outcomes for conditions like Alzheimer's and Parkinson's diseases.
Future work focusing on clinical applications could revolutionize treatment approaches for various neurological disorders.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Liao et al. (Wed,) studied this question.
synapsesocial.com/papers/69a75bebc6e9836116a241ef
https://doi.org/https://doi.org/10.1016/j.jconrel.2026.114665